Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes—A randomized placebo‐controlled crossover trial

The use of the sleep‐promoting hormone melatonin is rapidly increasing as an assumed safe sleep aid. During the last decade, accumulating observations suggest that melatonin affects glucose homeostasis, but the precise role remains to be defined. We investigated the metabolic effects of long‐term me...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauritzen, Esben S., Kampmann, Ulla, Pedersen, Mette G. B., Christensen, Lise‐Lotte, Jessen, Niels, Møller, Niels, Støy, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540532/
https://www.ncbi.nlm.nih.gov/pubmed/35619221
http://dx.doi.org/10.1111/jpi.12809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540532/
https://www.ncbi.nlm.nih.gov/pubmed/35619221
http://dx.doi.org/10.1111/jpi.12809

Ejemplares similares